Atlas Trials

A First Step Towards Ultra-hypofractionation for Unfavourable Intermediate and High-risk Prostate Cancer

Clinical trial NCT05361902 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05361902
Sponsor
Erasmus Medical Center
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2022-07-07
Primary completion
2024-06-13
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.